1. Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial. (September 2021) Authors: Denda, Tadamichi; Takashima, Atsuo; Gamoh, Makio; Iwanaga, Ichiro; Komatsu, Yoshito; Takahashi, Masanobu; Nakamura, Masato; Ohori, Hisatsugu; Sakashita, Akiko; Tsuda, Masahiro; Kobayashi, Yoshimitsu; Baba, Hideo; Kotake, Masanori; Ishioka, Chikashi; Yamada, Yasuhide; Sato, Atsushi; Yuki, Satoshi;... Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron. Issue 7 (27th May 2015) Authors: Komatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; I... Journal: Cancer science Issue: Volume 106:Issue 7(2015:Jul.) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron. Issue 7 (27th May 2015) Authors: Komatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; I... Journal: Cancer science Issue: Volume 106:Issue 7(2015:Jul.) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201). (18th March 2022) Authors: Kawamoto, Yasuyuki; Yuki, Satoshi; Meguro, Takashi; Hatanaka, Kazuteru; Uebayashi, Minoru; Nakamura, Michio; Okuda, Hiroyuki; Iwanaga, Ichiro; Kato, Takashi; Nakano, Shintaro; Sato, Atsushi; Harada, Kazuaki; Oba, Koji; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito Journal: Oncologist Issue: Volume 27:Number 5(2022) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP. (February 2015) Authors: Kobayashi, Yoshimitsu; Komatsu, Yoshito; Yuki, Satoshi; Fukushima, Hiraku; Sasaki, Takahide; Iwanaga, Ichiro; Uebayashi, Minoru; Okuda, Hiroyuki; Kusumi, Takaya; Miyagishima, Takuto; Sogabe, Susumu; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Nakamura, Michio; Konno, Jun; Yamamoto, Fumiya... Journal: Future oncology Issue: Volume 11:Number 4(2015) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP. (February 2015) Authors: Kobayashi, Yoshimitsu; Komatsu, Yoshito; Yuki, Satoshi; Fukushima, Hiraku; Sasaki, Takahide; Iwanaga, Ichiro; Uebayashi, Minoru; Okuda, Hiroyuki; Kusumi, Takaya; Miyagishima, Takuto; Sogabe, Susumu; Tateyama, Miki; Hatanaka, Kazuteru; Tsuji, Yasushi; Nakamura, Michio; Konno, Jun; Yamamoto, Fumiya... Journal: Future oncology Issue: Volume 11:Number 4(2015) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗